Cryptosporidiosis and the challenges of chemotherapy.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Drug resistance updates

• Publication date

  2002-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S1368-7646(02)00011-0PMID 12127863
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Infections of the Gastrointestinal Tract

  2010cited by this paper
• Characterization of an Intestinal Epithelial Cell Receptor Recognized by the Cryptosporidium parvum Sporozoite Ligand CSL

  2001cited by this paper
• The ABC transporter genes of Plasmodium falciparum and drug resistance.

  2001cited by this paper
• The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.

  2001cited by this paper
• A new approach for targeting to Cryptosporidium parvum using mucoadhesive nanosuspensions: research and applications.

  2001cited by this paper
• Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture.

  2001cited by this paper
• Dinitroaniline herbicides against protozoan parasites: the case of Trypanosoma cruzi.

  2001cited by this paper
• Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide.

  2001cited by this paper
• Evaluation of in vitro activity of aurones and related compounds against Cryptosporidium parvum.

  2001cited by this paper
• Gene discovery in Cryptosporidium parvum: expressed sequence tags and genome survey sequences.

  2000cited by this paper
• Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection

  2000cited by this paper
• Field trial on the therapeutic efficacy of paromomycin on natural Cryptosporidium parvum infections in lambs.

  2000cited by this paper
• What is the phylogenetic position of Cryptosporidium?

  2000cited by this paper
• Identification of Cryptosporidium parvum Dihydrofolate Reductase Inhibitors by Complementation in Saccharomyces cerevisiae

  2000cited by this paper
• Eradication of cryptosporidia and microsporidia following successful antiretroviral therapy.

  2000cited by this paper
• Confirmation of the Prophylactic Value of Paromomycin in a Natural Outbreak of Caprine Cryptosporidiosis

  2000cited by this paper
• Eradication of Cryptosporidia and Microsporidia Following Successful Antiretroviral Therapy

  2000cited by this paper
• Molecular analysis of a Type I fatty acid synthase in Cryptosporidium parvum.

  2000cited by this paper
• Cryptosporidium parvum appears to lack a plastid genome.

  2000cited by this paper
• Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group.

  2000cited by this paper
• [1N,12N]Bis(Ethyl)-cis-6,7-Dehydrospermine: a New Drug for Treatment and Prevention of Cryptosporidium parvum Infection of Mice Deficient in T-Cell Receptor Alpha

  2000cited by this paper
• Efficacy of nitazoxanide, tizoxanide and tizoxanide glucuronide against Cryptosporidium parvum development in sporozoite-infected HCT-8 enterocytic cells.

  2000cited by this paper
• CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages.

  1999cited by this paper
• Cryptosporidium is more closely related to the gregarines than to coccidia as shown by phylogenetic analysis of apicomplexan parasites inferred using small-subunit ribosomal RNA gene sequences

  1999cited by this paper
• Efficacy of Treatment with Paromomycin, Azithromycin, and Nitazoxanide in a Patient with Disseminated Cryptosporidiosis

  1999cited by this paper
• Protection of calves against cryptosporidiosis with immune bovine colostrum induced by a Cryptosporidium parvum recombinant protein.

  1999cited by this paper
• Food-related illness and death in the United States.

  1999cited by this paper
• Virulence of three distinct Cryptosporidium parvum isolates for healthy adults.

  1999cited by this paper
• Preliminary evidence for a mitochondrion in Cryptosporidium parvum: phylogenetic and therapeutic implications.

  1999cited by this paper
• A comparison of the effects of two dinitroanilines against Cryptosporidium parvum in vitro and in vivo in neonatal mice and rats.

  1999cited by this paper
• Hyperimmune bovine colostrum specific for recombinant Cryptosporidium parvum antigen confers partial protection against cryptosporidiosis in immunosuppressed adult mice.

  1999cited by this paper
• Improved efficacy of dinitroaniline analogs for use as anti-cryptosporidial drugs.

  1999cited by this paper
• Efficacy of Nitazoxanide againstCryptosporidium parvum in Cell Culture and in Animal Models

  1998cited by this paper
• Children with Cancer

  1998cited by this paper
• Combination drug therapy for cryptosporidiosis in AIDS.

  1998cited by this paper
• In-vitro activities of paromomycin and lasalocid evaluated in combination against Cryptosporidium parvum.

  1998cited by this paper
• Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy.

  1998cited by this paper
• Comparative Efficacy Evaluation of Dicationic Carbazole Compounds, Nitazoxanide, and Paromomycin againstCryptosporidium parvum Infections in a Neonatal Mouse Model

  1998cited by this paper
• Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators.

  1998cited by this paper
• Prophylactic effect of bovine anti-Cryptosporidium hyperimmune colostrum immunoglobulin in healthy volunteers challenged with Cryptosporidium parvum.

  1998cited by this paper
• AIDS-related cryptosporidial diarrhoea: an open study with roxithromycin.

  1998cited by this paper
• Eradication of Cryptosporidium in a child undergoing maintenance chemotherapy for leukemia using high dose azithromycin therapy.

  1998cited by this paper
• Paromomycin and Geneticin Inhibit IntracellularCryptosporidium parvum without Trafficking through the Host Cell Cytoplasm: Implications for Drug Delivery

  1998cited by this paper
• Evidence for the shikimate pathway in apicomplexan parasites

  1998cited by this paper
• Optical and radiocarbon dating at Jinmium rock shelter in northern Australia

  1998cited by this paper
• Roxithromycin treatment for diarrhoea caused by Cryptosporidium spp. in patients with AIDS.

  1998cited by this paper
• Synthesis and Evaluation of Dinitroanilines for Treatment of Cryptosporidiosis

  1998cited by this paper
• A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico.

  1998cited by this paper
• Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa.

  1997cited by this paper
• Characterization of an ATP-binding cassette transporter in Cryptosporidium parvum.

  1997cited by this paper
• Pilot studies of azithromycin, letrazuril and paromomycin in the treatment of cryptosporidiosis

  1997cited by this paper
• Accelerated inflammatory bowel disease of TCR-alpha-deficient mice persistently infected with Cryptosporidium parvum.

  1997cited by this paper
• Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites.

  1997cited by this paper
• Extrachromosomal DNA in the Apicomplexa.

  1997cited by this paper
• The role of drugs in the control of parasitic nematode infections: must we do without?

  1997cited by this paper
• Cryptosporidium and Cryptosporidiosis

  1997cited by this paper
• Characterization of anti-Toxoplasma activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in Toxoplasma physiology

  1997cited by this paper
• Polyamine biosynthesis in Cryptosporidium parvum and its implications for chemotherapy.

  1997cited by this paper
• A plastid organelle as a drug target in apicomplexan parasites

  1997cited by this paper
• Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro.

  1996cited by this paper
• Tratamento da criptosporidiase, em pacientes com AIDS, por meio da paromomicina

  1996cited by this paper
• Plasmodium vivax: in vitro antiparasitic effect of cyclosporins.

  1996cited by this paper
• Inhibition of Toxoplasma gondii replication by dinitroaniline herbicides.

  1996cited by this paper
• In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum.

  1996cited by this paper
• In vitro anticryptosporidial activity of dinitroaniline herbicides.

  1996cited by this paper
• Treatment of severe diarrhea caused by Cryptosporidium parvum with oral bovine immunoglobulin concentrate in patients with AIDS.

  1996cited by this paper
• [The treatment of cryptosporidiosis in AIDS patients using paromomycin].

  1996cited by this paper
• Clarithromycin prophylaxis against Cryptosporidium enteritis in patients with AIDS.

  1996cited by this paper
• Cryptosporidiosis: An Outbreak Associated with Drinking Water Despite State-of-the-Art Water Treatment

  1996cited by this paper
• Potential antifolate resistance determinants and genotypic variation in the bifunctional dihydrofolate reductase-thymidylate synthase gene from human and bovine isolates of Cryptosporidium parvum.

  1996cited by this paper
• 7 – Polyamine Metabolism

  1995cited by this paper
• Evaluation of maduramicin and alborixin in a SCID mouse model of chronic cryptosporidiosis

  1995cited by this paper
• Inhibition of cytoplasmic and organellar protein synthesis in Toxoplasma gondii. Implications for the target of macrolide antibiotics.

  1995cited by this paper
• Activity of benzimidazoles against cryptosporidiosis in neonatal BALB/c mice.

  1995cited by this paper
• Biochemistry and Molecular Biology of Parasites

  1995cited by this paper
• Chemoprophylaxis of Cryptosporidium parvum infection with paromomycin in kids and immunological study

  1995cited by this paper
• Evaluation of a two-phase scid mouse model preconditioned with anti-interferon-gamma monoclonal antibody for drug testing against Cryptosporidium parvum.

  1995cited by this paper
• Intestinal and extraintestinal cryptosporidiosis in AIDS patients

  1995cited by this paper
• Therapeutic efficacy of paromomycin in immunosuppressed adult mice infected with Cryptosporidium parvum.

  1995cited by this paper
• Massive outbreak of waterborne cryptosporidium infection in Milwaukee, Wisconsin: recurrence of illness and risk of secondary transmission.

  1995cited by this paper
• Cryptosporidium and cryptosporidiosis in man and animals.

  1995cited by this paper
• Antiprotozoal activities of benzimidazoles and correlations with beta-tubulin sequence

  1994cited by this paper
• A Phase I study of letrazuril in AIDS‐related Cryptosporidiosis

  1994cited by this paper
• Cryptosporidium and microsporidial beta-tubulin sequences: predictions of benzimidazole sensitivity and phylogeny.

  1994cited by this paper
• Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial.

  1994cited by this paper
• Cryptosporidiosis.

  1993cited by this paper
• Paromomycin is effective as prophylaxis for cryptosporidiosis in dairy calves.

  1993cited by this paper
• Azithromycin for treatment of severe Cryptosporidium diarrhea in two children with cancer.

  1993cited by this paper
• Immunotherapy of cryptosporidiosis in immunodeficient animal models.

  1991cited by this paper
• Activity of azithromycin against cryptosporidia in immunosuppressed rats.

  1991cited by this paper
• Inhibition of Cryptosporidium parvum in neonatal Hsd:(ICR)BR Swiss miceby polyether ionophores and aromatic amidines

  1991cited by this paper
• Chemotherapeutic effect of azithromycin and lasalocid on Cryptosporidium infection in mice.

  1991cited by this paper
• Anti-cryptosporidial activity of macrolides in immunosuppressed rats.

  1991cited by this paper
• Efficacy of halofuginone lactate against Cryptosporidium parvum in calves

  1991cited by this paper
• Anti-cryptosporidial activity of macrolides in immunosuppressed rats.

  1991cited by this paper
• Cryptosporidiosis

  1991cited by this paper
• 7 – Polyamine Metabolism

  1990cited by this paper
• Cessation of Cryptosporidium-associated diarrhea in an acquired immunodeficiency syndrome patient after treatment with hyperimmune bovine colostrum.

  1990cited by this paper
• Treatment Strategies for Cryptosporidiosis

  1990cited by this paper
• Treatment with bovine hyperimmune colostrum of cryptosporidial diarrhea in AIDS patients.

  1990cited by this paper

• Biosynthesized Zinc Oxide Nanoparticles Regulating Immune Response and Liver Enzymes in Reducing Inflammation from Cryptosporidiosis-induced Infection

  2025cites this paper
• Investigating Cryptosporidium spp. Using Genomic, Proteomic and Transcriptomic Techniques: Current Progress and Future Directions

  2023cites this paper
• Cryptosporidiosis: From Prevention to Treatment, a Narrative Review

  2022cites this paper
• Deep glance on the antiparasitic anticancer activities of wheat germ oil in chronically infected immunosuppressed mice with cryptosporidiosis

  2022cites this paper
• EVALUATION OF LACTOBACILLUS ACIDOPHILUS, CHITOSAN AND/OR AZITHROMYCIN IN TREATING CRYPTOSPORIDIOSIS IN NEONATAL MICE

  2022cites this paper
• Molecular Basis of P131 Cryptosporidial-IMPDH Selectivity—A Structural, Dynamical and Mechanistic Stance

  2020cites this paper
• Therapeutic Efficacy of Ginger (Zingiber officinale), Ginseng (Panax ginseng) and Sage (Salvia officinalis) Against Cryptosporidium parvum in Experimentally Infected Mice

  2020cites this paper
• Prevalence of Intestinal Cryptosporidiosis in Malaysian Children with Malignancies

  2019cites this paper
• Immunohistochemical Detection of Cryptosporidium-Induced Intestinal Tissue Alterations in Dexamethasone Treated & Un-Treated Mice

  2018cites this paper
• DETECTION OF CRYPTOSPORIDIUM-INDUCED INTESTINAL TISSUE ALTERATIONS IN DEXAMETHASONE TREATED & UN-TREATED MICE

  2018cites this paper
• Curcumin: A promising treatment for Cryptosporidium parvum infection in immunosuppressed BALB/c mice.

  2018cites this paper
• Effect of Egyptian propolis on cryptosporidiosis in immunosuppressed rats with special emphasis on oocysts shedding, leukogram, protein profile and ileum histopathology.

  2017cites this paper
• Necessity of Bumped Kinase Inhibitor Gastrointestinal Exposure in Treating Cryptosporidium Infection

  2017cites this paper
• Bumped-Kinase Inhibitors for Cryptosporidiosis Therapy

  2017cites this paper
• Serological detection and epidemiology of Neospora caninum and Cryptosporidium parvum antibodies in cattle in southern Egypt.

  2016cites this paper
• Removing Cryptosporidium-size microspheres with polyaluminium FeCl3

  2016cites this paper
• Cryptosporidiosis in a buffalo calf at Meerut, Uttar Pradesh and its successful therapeutic management

  2016cites this paper
• Binding mode of inhibitors and Cryptosporidium parvum IMP dehydrogenase: A combined ligand- and receptor-based study

  2015cites this paper
• Three-dimensional structures in the design of therapeutics targeting parasitic protozoa: reflections on the past, present and future.

  2015cites this paper
• Parasitic diarrheal disease: drug development and targets

  2015cites this paper
• A nanotherapy strategy significantly enhances anticryptosporidial activity of an inhibitor of bifunctional thymidylate synthase-dihydrofolate reductase from Cryptosporidium.

  2015cites this paper
• Prevalence, water borne transmission and chemotherapy of cryptosporidiosis in small ruminants.

  2015cites this paper
• Cryptosporidium parvum has an active hypusine biosynthesis pathway.

  2014cites this paper
• Synthesis, in Vitro Evaluation and Cocrystal Structure of 4-Oxo-[1]benzopyrano[4,3-c]pyrazole Cryptosporidium parvum Inosine 5′-Monophosphate Dehydrogenase (CpIMPDH) Inhibitors

  2014cites this paper
• Epidemiological investigations on the public health significance of Cryptosporidium parasites in livestock and people in the Ismailia Canal Zone of Egypt

  2014cites this paper
• Exploring novel strategies for AIDS protozoal pathogens: α-helix mimetics targeting a key allosteric protein-protein interaction in C. hominis TS-DHFR.

  2013cites this paper
• Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.

  2013cites this paper
• A Cysteine Protease Inhibitor Rescues Mice from a Lethal Cryptosporidium parvum Infection

  2013cites this paper
• Description of fecal shedding of Cryptosporidium parvum oocysts in experimentally challenged dairy calves

  2013cites this paper
• Treating Cryptosporidium parvum Infection in Calves

  2013cites this paper
• Infection from a Lethal Cryptosporidium parvum A Cysteine Protease Inhibitor Rescues Mice

  2013cites this paper
• Optimization of benzoxazole-based inhibitors of Cryptosporidium parvum inosine 5'-monophosphate dehydrogenase.

  2013cites this paper
• Analysis of Monensin Sensitivity in Toxoplasma gondii Reveals Autophagy as a Mechanism for Drug Induced Death

  2012cites this paper
• Drug combination therapy in control of cryptosporidiosis in Ludhiana district of Punjab

  2012cites this paper
• Contamination of irrigation systems of dental units with Cryptosporidium species in Alexandria, Egypt: a neglected disinfection pitfall

  2012cites this paper
• Contamination of irrigation systems of dental units with Cryptosporidium species in Alexandria, Egypt: a neglected disinfection pitfall

  2012cites this paper
• Genetic mapping and coccidial parasites: Past achievements and future prospects

  2012cites this paper
• Novel anti-Cryptosporidium activity of known drugs identified by high-throughput screening against parasite fatty acyl-CoA binding protein (ACBP).

  2012cites this paper
• ABC transporters involved in drug resistance in human parasites.

  2011cites this paper
• Efficacy of ginkgolic acids against Cryptosporidium andersoni in cell culture

  2011cites this paper
• Diarrhea due to Cryptosporidium parvum in immunocompromised and immunocompetent patients in Khartoum State

  2011cites this paper
• The State of Research for AIDS-Associated Opportunistic Infections and the Importance of Sustaining Smaller Research Communities

  2011cites this paper
• Epidemiologic characterization of cryptosporidiosis in cattle in the Center Sabana region (Cundinamarca).

  2010cites this paper
• Genetic richness and diversity in Cryptosporidium hominis and C. parvum reveals major knowledge gaps and a need for the application of "next generation" technologies--research review.

  2010cites this paper
• Prodrug Activation by Cryptosporidium Thymidine Kinase*

  2010cites this paper
• Cryptosporidiosis in people: it's not just about the cows.

  2010cites this paper
• Successful treatment of cryptosporidiosis in 2 common marmosets (Callithrix jacchus) by using paromomycin.

  2010cites this paper
• Molecular analysis of Cryptosporidium parvum HNJ-1 isolated in Japan.

  2010cites this paper
• Cryptosporidium genotypes and subtypes in dairy calves in Egypt.

  2010cites this paper
• DNA topoisomerases in apicomplexan parasites: promising targets for drug discovery

  2010cites this paper
• Caracterización epidemiológica de la criptosporidiosis en bovinos en la región sabana centro (Cundinamarca)

  2010cites this paper
• Functional Expression of a DNA-Topoisomerase IB from Cryptosporidium parvum

  2009cites this paper
• CRYPTOSPORIDIUM AND CRYPTOSPORIDIOSIS: A BRIEF REVIEW

  2009influential citation
• Human cryptosporidiosis: a review.

  2009cites this paper
• High resolution melting-curve (HRM) analysis for the diagnosis of cryptosporidiosis in humans.

  2009cites this paper
• Functional characterization of acyl-CoA binding protein (ACBP) and oxysterol binding protein-related proteins (ORPS) from Cryptosporidium parvum

  2009cites this paper
• Long-term consequences of Cryptosporidium infections in immunocompetent and immunodeficient individuals.

  2009cites this paper
• Functional characterization of the nucleotide binding domain of the Cryptosporidium parvum CpABC4 transporter: an iron-sulfur cluster transporter homolog.

  2009cites this paper
• Drug Resistance and Emerging Targets in the Opportunistic Pathogens Toxoplasma gondii and Cryptosporidium parvum

  2009cites this paper
• An apicomplexan ankyrin-repeat histone deacetylase with relatives in photosynthetic eukaryotes.

  2009cites this paper
• Novel non-active site inhibitor of Cryptosporidium hominis TS-DHFR identified by a virtual screen.

  2009cites this paper
• Targeting a prokaryotic protein in a eukaryotic pathogen: identification of lead compounds against cryptosporidiosis.

  2008cites this paper
• Classification of Cryptosporidium Species from Patients with Sporadic Cryptosporidiosis by Use of Sequence-Based Multilocus Analysis following Mutation Scanning

  2008cites this paper
• Analysis of the genetic diversity within Cryptosporidium hominis and Cryptosporidium parvum from imported and autochtonous cases of human cryptosporidiosis by mutation scanning

  2008cites this paper
• Cryptosporidium--biotechnological advances in the detection, diagnosis and analysis of genetic variation.

  2008cites this paper
• Fine targeting of purine salvage in Cryptosporidium parasites.

  2008cites this paper
• Moluscos bivalves destinados ao consumo humano como vetores de protozoários patogênicos: Metodologias de detecção e normas de controle Bivalve molluscs destined for human consumption as vectors of pathogenic protozoa: Detection methodologies and control rules

  2008cites this paper
• Targeting a uniquely nonspecific prenyl synthase with bisphosphonates to combat cryptosporidiosis.

  2008cites this paper
• Grêle parasitaire

  2008cites this paper
• Cryptosporidium parvum: enhancing our understanding of its unique fatty acid metabolism and the elucidation of putative new inhibitors

  2008influential citation
• Classification of Cryptosporidium Species from Patients with Sporadic Cryptosporidiosis by Use of Sequence-Based Multilocus Analysis following Mutation Scanning (cid:1)

  2008cites this paper
• The suppressive effect of Mekabu fucoidan on an attachment of Cryptosporidium parvum oocysts to the intestinal epithelial cells in neonatal mice.

  2007cites this paper
• Protein kinases as targets for antiparasitic chemotherapy drugs.

  2007cites this paper
• Prevention and treatment of cryptosporidiosis in immunocompromised patients.

  2007cites this paper
• The effect of blueberry extracts on Giardia duodenalis viability and spontaneous excystation of Cryptosporidium parvum oocysts, in vitro.

  2007cites this paper
• Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis.

  2007cites this paper
• The functional characterization of apicomplexan Type II fatty acid synthesis in Toxoplasma gondii

  2006cites this paper
• Colites parasitaires et immunodéficiences

  2006cites this paper
• Niche metabolism in parasitic protozoa

  2006cites this paper
• The plastid-derived organelle ofprotozoan human parasites asa target of established and emerging drugs

  2005cites this paper
• Localized glucose and water influx facilitates Cryptosporidium parvum cellular invasion by means of modulation of host-cell membrane protrusion.

  2005cites this paper
• Cryptosporidium parvum: effect of multi-drug reversing agents on the expression and function of ATP-binding cassette transporters.

  2004cites this paper
• Phylogenomic evidence supports past endosymbiosis, intracellular and horizontal gene transfer in Cryptosporidium parvum

  2004cites this paper
• Present and future control of cryptosporidiosis in humans and animals

  2004cites this paper
• New drugs and treatment for cryptosporidiosis

  2004cites this paper
• Estudo da ocorrência de infecção por Cryptosporidium spp (Apicomplexa: Cryptospordiidae) entre crianças do município de Taubaté- SP e caracterização genotípica de isolados clínicos do parasito

  2004cites this paper
• Genomics meets transgenics in search of the elusive Cryptosporidium drug target.

  2004cites this paper
• Cryptosporidium parvum IMP Dehydrogenase

  2004cites this paper
• Gene transfer in the evolution of parasite nucleotide biosynthesis.

  2004cites this paper
• A role for coccidian cGMP-dependent protein kinase in motility and invasion.

  2004cites this paper
• Management of protozoa-related diarrhea in HIV infection

  2003cites this paper
• A review of chemotherapeutic approaches to the treatment of cryptosporidiosis

  2003cites this paper